We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ProBioGen AG, a premier German service & technology provider for complex biologics, announced the launch of DirectedLuck, a highly active transposase equipped for specific epigenetic targeting.